文献速递抗菌药物管理治疗药物监测与药物基因组学

降钙素原联合临床决策支持工具评估呼吸道感染抗菌治疗疗程的效用

Evaluating the utility of procalcitonin and a clinical decision support tool to determine duration of antimicrobial therapy for respiratory tract infections.
PubMed 文献 · Am J Health Syst Pharm · 2024-01-01

该准实验研究评估了药师 stewardship 干预联合临床决策支持(CDS)工具与降钙素原(PCT)评估对呼吸道感染(RTI)抗菌药物疗程的影响。干预组(104例)中位抗菌药物疗程为3天(IQR 2-4天),低于干预前组(90例)的4天(IQR 2.8-5天),差异有统计学意义(P=0.001)。结果表明该联合策略可缩短RTI抗菌治疗疗程。

要点

  • PCT<0.25 ng/mL且使用RTI抗菌药物时,CDS工具提醒药师进行前瞻性审核反馈。
  • 干预组中位抗菌药物疗程3天,短于干预前组的4天(P=0.001)。
  • 药师干预联合CDS与PCT可能有助于缩短呼吸道感染抗菌治疗疗程。

核心结论

  • 药师干预联合CDS与PCT可缩短呼吸道感染处方抗菌药物的疗程。

研究设计与样本

  • 准实验研究,干预前组为2021年4月至6月入院患者(90例),干预组为2022年4月至6月入院患者(104例)。
  • 干预阶段使用CDS工具在患者PCT<0.25 ng/mL且使用RTI抗菌药物时提醒临床药师,药师通过前瞻性审核与反馈进行干预。

主要发现

  • 干预组中位抗菌药物疗程为3天(IQR 2-4天),干预前组为4天(IQR 2.8-5天),P=0.001。
  • 两组基线特征匹配不佳,但偏向干预前组。

关键数值与推荐

  • CDS工具激活条件:报告的PCT水平<0.25 ng/mL且患者正在使用针对RTI处方的抗菌药物。

临床怎么用

  • 抗菌药物管理项目可考虑实施PCT联合CDS与药师干预的 bundle 以缩短RTI抗菌治疗疗程。

局限性

  • 基线特征在组间匹配不佳,且偏向干预前组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Procalcitonin (PCT) levels may play a role in decreasing the duration of antimicrobial therapy in institutions that have long durations of therapy for management of community-acquired pneumonia. We assessed the impact of the combination of pharmacist stewardship interventions assisted by a clinical decision support (CDS) tool and PCT assessment on the antimicrobial days of therapy (DOT) prescribed for respiratory tract infections (RTIs). METHODS: We conducted a quasi-experimental study in which patients in the preintervention group were admitted between April and June 2021 and patients in the intervention group were admitted between April and June 2022. In the intervention phase, a CDS tool was utilized to alert clinical pharmacists when patients met specific criteria. This alert was programmed to activate for individual patients when a reported PCT level was less than 0.25 ng/mL and the patient was on antimicrobials prescribed for an RTI as indicated by providers in the electronic health record. Stewardship interventions were made by pharmacists via prospective audit and feedback. The primary endpoint was inpatient antimicrobial DOT for RTIs. RESULTS: There were 90 patients in the preintervention group and 104 patients in the intervention group. Although baseline characteristics were not well matched between the groups, favoring the preintervention group, the median DOT was lower in the intervention group, at 3 days (interquartile range [IQR], 2-4 days), compared to 4 days (IQR, 2.8-5 days) in the preintervention group (P = 0.001). CONCLUSION: The results of our study demonstrate the utility of pharmacist interventions coupled with CDS and PCT in reducing antimicrobial DOT prescribed for RTIs. Antimicrobial stewardship programs may benefit from implementing a PCT bundle.

来源:Am J Health Syst Pharm,查看原文。版权归原作者所有。

引用

  1. Pevehouse R, Shah PJ, Chou N, et al. Evaluating the utility of procalcitonin and a clinical decision support tool to determine duration of antimicrobial therapy for respiratory tract infections. Am J Health Syst Pharm. 2024. PMID: 38488695. doi:10.1093/ajhp/zxae072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。